N4 Pharma ( (GB:N4P) ) has shared an update.
N4 Pharma Plc has announced a change in its major holdings, with Tracarta Limited now holding 18.02% of the voting rights. This notification follows the dematerialization of holdings into Fiske Nominees Limited, reflecting a significant shift in the company’s shareholder structure. The change in holdings could impact the company’s strategic decisions and influence its market positioning.
More about N4 Pharma
N4 Pharma Plc is a UK-based pharmaceutical company that focuses on developing novel drug delivery systems. The company is primarily engaged in the research and development of innovative solutions to improve the delivery and efficacy of existing drugs, with a market focus on enhancing pharmaceutical formulations.
Average Trading Volume: 1,906,456
Technical Sentiment Signal: Sell
Current Market Cap: £7.39M
See more data about N4P stock on TipRanks’ Stock Analysis page.